News | October 06, 2008

TCT 2008 Begins This Weekend in Washington, D.C.

October 7, 2008 - Now in its 20th year the 2008 Transcatheter Cardiovascular Therapeutics (TCT) symposium, sponsored by the Cardiovascular Research Foundation, will take place from Sunday, Oct. 12 through Friday, Oct. 17 at the Washington Convention Center in Washington, D.C.

TCT is said to be the world’s premier conference in interventional cardiology, endovascular medicine, and structural heart disease, where the latest trends, research findings, and techniques are disseminated to practicing physicians from around the world. The symposium will feature live procedures originating from more than 25 leading U.S. and international medical centers featuring world-renowned operators performing complex interventions. Cases will be presented with an interactive and thematic approach in three distinct tracks for coronary, endovascular, and structural heart disease.

Diagnostic and Invasive Cardiology magazine has created the TCT FastPass Web site to guide clinicians through the products being highlighted by manufacturers at the show, and to update them with the latest technology news coming out of the event. Visit new.reillycomm.com/tct/.

For more information: www.tctconference.com


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now